The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AC1LD8VU     pyridine-3-carboxylic acid

Synonyms: 2906-42-5, nicotinic acid, [carboxy-14C]-, 3-Pyridinecarboxylic-14C acid (9CI)
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of nicotinic acid

  • We concluded that 1) basal plasma FFAs exerted physiologically important, long-lasting effects supporting 25-33% of basal insulin secretion in nondiabetic and diabetic subjects; 2) basal plasma FFAs were responsible for some of the hyperinsulinemia in normoglycemic obese subjects; and 3) NA had no direct effect on insulin secretion [1].
  • 14C-Nicotinic acid (NA) incorporation into nicotinamide adenine dinucleotide (NAD) was studied in cultures from 7 normal human pituitaries and 13 chromophobe adenomas [2].
 

High impact information on nicotinic acid

  • In summary, our data suggest that (a) acute changes in plasma FFA produce acute changes in GNG and reciprocal changes in GL; (b) the decrease in EGP between 16 and 24 hours of fasting is due to a fall in GL; and (c) NA has no direct effect on GNG [3].
  • CONCLUSIONS: Short-term beta-cell compensation to NA-induced insulin resistance was incomplete and did not differ by genetic predisposition [4].
  • Phosphorylation of p38 MAPK was increased (P<0.05) by NA treatment at rest, and this correlated (r2=0.84, P<0.01) with increased PGC1alpha [5].
  • Hence, despite the fact that NA ingestion decreased FFA availability, it promoted the induction of PPARalpha/delta and PGC1alpha gene expression to a similar degree as prolonged exercise [5].
  • The HDL/LDL ratio was higher on NA than clofibrate (0.47 +/- 0.19 vs. 0.38 +/- 0.09, P less than 0.05) [6].
 

Biological context of nicotinic acid

  • These studies suggest that the induction of insulin resistance with NA is associated with changes in the fatty acid composition of PC in man [7].
  • Data on other pharmacological properties of beta-PC and/or NA that might contribute to antihyperlipidemic efficacy (e.g., fibrinolysis, inhibition of platelet aggregation, erythrocyte membrane changes) were also included where available [8].
  • NA causes vasodilation via the activation of phospholipase A2 (PLA2) leading to the release of free fatty acids from membrane phospholipids and the subsequent production of prostaglandins [9].
 

Anatomical context of nicotinic acid

  • Results Vastus lateralis IMCL was significantly elevated in LC (13.3 +/- 1.1 x 10(-3)) and LC + NA (13.5 +/- 1.1 x 10(-3)) (P < 0.01 for both), but was not different between conditions (P > 0.05) [10].
  • To evaluate the hypothesis that NA, LVP and adrenaline release PA from the endothelial cells of the vessel wall through their common effect on vascular motility, PA has been characterized by means of a histochemical technique on vein biopsies obtained from human volunteers after infusion of the compounds [11].
  • In vitro control studies revealed that NA did not have a direct effect on skeletal muscle LPL activity [12].
  • The excretion of 14C after SN in the urine is about half of that after NA whereas excretion in the feces is several times greater [13].
 

Associations of nicotinic acid with other chemical compounds

 

Gene context of nicotinic acid

  • To assess the effect of lipolytic suppression on the exercise-induced IL-6 response, seven active, but not specifically trained, men performed two experimental exercise trials with (NA) or without [control (Con)] NA ingestion 60 min before (10 mg/kg body mass) and throughout (5 mg/kg body mass every 30 min) exercise [16].
  • However, even in these subjects, HSL activity was not further increased during the NA trial [17].
 

Analytical, diagnostic and therapeutic context of nicotinic acid

  • The extent of the hyperbilirubinemic response to NA load, and of the NA half-life, together with physical examination over a one-year period were in good agreement with the diagnosis of Gilbert's syndrome in the patient's father and siblings [18].

References

  1. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Boden, G., Chen, X., Iqbal, N. Diabetes (1998) [Pubmed]
  2. Pyridine nucleotide synthesis in normal and neoplastic human pituitary cells in culture. Gross, C.J., Harris, R.D., Seljeskog, E.L., Henderson, L.M. Cancer (1983) [Pubmed]
  3. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. Chen, X., Iqbal, N., Boden, G. J. Clin. Invest. (1999) [Pubmed]
  4. Effects of short-term experimental insulin resistance and family history of diabetes on pancreatic beta-cell function in nondiabetic individuals. Rasouli, N., Hale, T., Kahn, S.E., Spencer, H.J., Elbein, S.C. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  5. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. Watt, M.J., Southgate, R.J., Holmes, A.G., Febbraio, M.A. J. Mol. Endocrinol. (2004) [Pubmed]
  6. Treatment of type III hyperlipoproteinemia with four different treatment regimens. Hoogwerf, B.J., Bantle, J.P., Kuba, K., Frantz, I.D., Hunninghake, D.B. Atherosclerosis (1984) [Pubmed]
  7. Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Clore, J.N., Harris, P.A., Li, J., Azzam, A., Gill, R., Zuelzer, W., Rizzo, W.B., Blackard, W.G. Metab. Clin. Exp. (2000) [Pubmed]
  8. Antihyperlipidemic properties of beta-pyridylcarbinol. A review of preclinical studies. Cohen, M. Life Sci. (1985) [Pubmed]
  9. Phospholipid and eicosanoid signaling disturbances in schizophrenia. Ross, B.M. Prostaglandins Leukot. Essent. Fatty Acids (2003) [Pubmed]
  10. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated. Johnson, N.A., Stannard, S.R., Rowlands, D.S., Chapman, P.G., Thompson, C.H., Sachinwalla, T., Thompson, M.W. Diabet. Med. (2006) [Pubmed]
  11. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Mannucci, P.M., Aberg, M., Nilsson, I.M., Robertson, B. Br. J. Haematol. (1975) [Pubmed]
  12. Physical inactivity amplifies the sensitivity of skeletal muscle to the lipid-induced downregulation of lipoprotein lipase activity. Zderic, T.W., Hamilton, M.T. J. Appl. Physiol. (2006) [Pubmed]
  13. On the absorption, distribution and excretion of sorbinicate in the rat and the monkey. Giachetti, C., Mondino, A., Silvestri, S., Zanolo, G., Bramanti, G., Criscuoli, M., Subissi, A. Arzneimittel-Forschung. (1982) [Pubmed]
  14. Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats. Lee, J.Y., Warner, R.B., Brune, M.E., Adler, A.L., Winn, M., De, B., Zydowsky, T.M., Opgenorth, T.J., Kerkman, D.J., DeBernardis, J.F. Am. J. Hypertens. (1994) [Pubmed]
  15. Adsorption of aromatic organic acids onto high area activated carbon cloth in relation to wastewater purification. Ayranci, E., Duman, O. J. Hazard. Mater. (2006) [Pubmed]
  16. Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. Holmes, A.G., Watt, M.J., Febbraio, M.A. J. Appl. Physiol. (2004) [Pubmed]
  17. Effects of reduced free fatty acid availability on hormone-sensitive lipase activity in human skeletal muscle during aerobic exercise. O'Neill, M., Watt, M.J., Heigenhauser, G.J., Spriet, L.L. J. Appl. Physiol. (2004) [Pubmed]
  18. Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. Gentile, S., Del Vecchio Blanco, C., Persico, M., Marmo, R., Coltorti, M. Hepatogastroenterology (1986) [Pubmed]
 
WikiGenes - Universities